日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia

一项开放标签、随机临床试验,旨在比较伊维菌素联合乙胺嗪和阿苯达唑与乙胺嗪联合阿苯达唑治疗印度尼西亚布鲁氏丝虫病的耐受性和疗效。

Supali, Taniawati; Djuardi, Yenny; Christian, Michael; Iskandar, Elisa; Alfian, Rahmat; Maylasari, Roospita; Destani, Yossi; Lomiga, Adriani; Minggu, Dominikus; Lew, Daphne; Bogus, Joshua; Weil, Gary J; Fischer, Peter U

Comparison of the Impact of Annual and Semiannual Mass Drug Administration on Lymphatic Filariasis Prevalence in Flores Island, Indonesia

印度尼西亚弗洛勒斯岛淋巴丝虫病流行率中年度和半年一次大规模药物管理的影响比较

Supali, Taniawati; Djuardi, Yenny; Lomiga, Adriani; Nur Linda, Sovie; Iskandar, Elisa; Goss, Charles W; Miller, John Philip; Weil, Gary J; Fischer, Peter U